A B S T R A C T We have studied the distribution of folate coenzyme forms in cultured human fibroblasts from control lines and from lines derived from nine patients representing all of the published reports of 5,10-CH2-H4PteGlu reductase deficiency. Based on mobility on DEAE-Sephadex and differential microbiological assay the major folate fractions in extracts of human fibroblasts were 5-CH3-H4PteGlu, 10-CHOH4PteGlu, and 5-CHO-H4PteGlu with smaller fractions, which included 5-CH3-H2PteGlu, 10-CHO-PteGlu, and H4PteGlu. Evidence that the 5-CHO-H4PteGlu may have been derived from 5,10-CH=H4PteGlu during extraction is presented. In most ofthe mutant fibroblasts the absolute concentration of 5-CH3-H4PteGlu was lower than in control cells but the proportion of intracellular folate which was 5-CH3-H4PteGlu was strikingly lower in mutant cells when determined by chromatography or differential microbiological assay. In both control and mutant cells most of the 5-CH3-H4-PteGlu was polyglutamate. 18 December 1978. served between the proportion of cellular folate which was 5-CH3-H4PteGlu, and both the clinical severity of this disorder and the residual enzyme activity indicating that the distribution of different folates may be an important control of intracellular folate metabolism. These studies indicate that 5,10-CH2-H4PteGlu reductase is the only significant intracellular pathway for the generation of 5-CH3-H4PteGlu, that the activity of this enzyme regulates the level of this folate in control and mutant cells under conditions of culture used here, that the majority of intracellular folate is in the polyglutamate form, and that the relative distribution of folates may control folate metabolism by interaction in the various folate reactions.
A B S T R A C T We have studied the distribution of folate coenzyme forms in cultured human fibroblasts from control lines and from lines derived from nine patients representing all of the published reports of 5,10-CH2-H4PteGlu reductase deficiency. Based on mobility on DEAE-Sephadex and differential microbiological assay the major folate fractions in extracts of human fibroblasts were 5-CH3-H4PteGlu, 10-CHOH4PteGlu, and 5-CHO-H4PteGlu with smaller fractions, which included 5-CH3-H2PteGlu, 10-CHO-PteGlu, and H4PteGlu. Evidence that the 5-CHO-H4PteGlu may have been derived from 5,10-CH=H4PteGlu during extraction is presented. In most ofthe mutant fibroblasts the absolute concentration of 5-CH3-H4PteGlu was lower than in control cells but the proportion of intracellular folate which was 5-CH3-H4PteGlu was strikingly lower in mutant cells when determined by chromatography or differential microbiological assay. In both control and mutant cells most of the 5-CH3-H4-PteGlu was polyglutamate. The proportion of intracellular folate which was polyglutamate was similar in control and mutant cells. A direct relationship was ob-
INTRODUCTION
Deficiency of 5,10-CH2-H4PteGlu reductase, (EC. 1.1.-1.68) an autosomal recessive inborn error of folate metabolism, is characterized by moderate degrees of homocystinemia and homocystinuria accompanied by normal or low plasma methionine levels. The clinical findings in the twelve patients described to date (1) (2) (3) (4) (5) (6) (7) (8) has ranged from seizures, apnea, coma, and death in infancy (4) to mild mental retardation and neurological impairment in adolescence (5) . The deficiency of 5,10-CH2-H4PteGlu reductase was first described in fibroblasts (3, 5, 9) but has now been confirmed in liver (4, 6) , kidney (4) , brain (4) , and leukocytes (3, 4) . Preliminary studies showed a decreased ratio of 5-CH3-H4PteGlu to total folates in the fibroblasts of several deficient patients (10) and an absence of 5-CH3-H4PteGlu in the serum and erythrocytes of one patient (4) has been described.
This study describes the distribution of folate monoglutamates and folate polyglutamates and the composition of each in fibroblasts from nine patients representing all of the published reports of 5,10-CH2-H4PteGlu reductase deficiency. (12) . 5,10-CH2-H4PteGlu reductase activity in cell extracts were measured as previouslv described (13) . Folate determinations. Folate was assayed microbiologically with Lactobacillus casei ATCC 7469, Pediococcus cerevisiae ATCC 8081, and Streptococcus fecalis ATCC 8083, using aseptic addition of samples to sterile medium already inoculated with assay organisms as described previously (14) . This technique represented a slight variation of standard techniques. Because S. fecalis required a higher folate concentration than the other organisms for logarithmic growth, folate concentration in fibroblasts could not always be reliably determined with this organism.
METHODS
For fractionation of folates on Sephadex G-25, washed fibroblasts were extracted in 0.05 M sodium phosphate pH 9 containing 8.5 mM ascorbate, protein precipitated with heat, and the clear supemate obtained after centrifugation was analyzed. For assay of folate content by microbiological methods and by DEAE-Sephadex, fibroblasts were extracted in 0.1 M sodium acetate pH 4.5 containing 8.5 mM ascorbate, and the extract was treated with 10% (vol/vol) of folate-depleted normal human serum for 90 min at 370C followed by heating and analysis of the supernate. The pH of the mixture of extract serum and buffer was 5.2-5.3.
Fractionation offolate on DEAE-Sephadex was as described previously (15, 16 ) using a linear gradient (0.1-0.8 M) of potassium phosphate pH 6.1. Folate polyglutamates were differentiated from short-chain folates in extracts untreated with conjugase by filtering through Sephadex G-25 as described previously (17) . To allow assay of the relatively small amount of Pediococcus-active folate from specimens containing 106 cells, filtration utilized a column of 0.9 x 30 cm, and 1-ml fractions were collected.
Folate polyglutamates were deconjugated to monoglutamates with 10% folate-depleted serum within the assay tubes at pH 4.5, after which the pH was adjusted to 6.9 and 0.8 ml of each fraction was mixed with concentrated assay medium containing the assay organism, and incubated without precipitation of protein. Standards and controls were assayed in a similar fashion. These samples were assayed only with L. casei and P. cerevisiae. This technique allowed assay of as little as 500 pg/sample. When fibroblast folate excluded from the gel was refiltered, it was again excluded from the gel. When the extract was treated with conjugase before filtration, all the folate filtered within the included volume of the gel, indicating that the technique differentiated between polyglutamyl and short-chain folates.
For the microbiological assays, care was taken to ensure that the samples were diluted into the range where growth of the microorganism was directly proportional to the folate concentration (18) . In all circumstances at least two dilutions within this assay range were achieved and concentrations calculated from these different dilutions were within 5% of each other.
Statistical analysis employed the Student t test, using paired or unpaired observations, and the Mann-Whitney analysis for nonparametric statistics. When not otherwise qualified, P values indicate the probability that values are different based on unpaired t test analysis.
The distribution of folate forms at confluence was determined by chromatography ofdeconjugated extracts on DEAESephadex. Typical (Table III) the proportion of intracellular folate which was 5-CH3-H4-PteGlu was significantly lower in mutant cells (P = 0.019 and 0.0004, respectively) and the proportion of fractions I and II are possibly higher in mutant cells (P = 0.09 and 0.14 Student; P = 0.04 and 0.04
Manni-Whitney).
The proportion of intracellular folate which was 5-CH3-H4PteGlu determined by differential microbiological assay alone correlates well with that calculated from column chromatography (r = 0.90, P = 0.0008 [Student] ), but the results from the former were consistently higher than from those from the column (leastsquares analysis of the data in Tables II and III differential microbiological assay, and x, that calculated from column chromatography). An attempt was made to determine ifthe distribution of nonmethylated folates observed in the cell extracts reflected the distribution of these within the cells before extraction. To determine if the 5-CHO-H4PteGlu found in the extracts could have come from 5,10-CH=H4PteGlu, the latter was prepared by acid incubation (20) from commercial 5-CHO-H4PteGlu and purified by chromatography. This material, the identity of which was verified spectrophotometrically, was mixed with serum and treated exactly as was a cell extract. All of the 5,10-CH=H4PteGlu was converted to 10-CHO-H4PteGlu, 10-CHO-PteGlu, and 5-CHOH4PteGlu. The largest fraction formed was 5-CHOH4PteGlu, suggesting that this material could have been formed from 5,10-CH=H4PteGlu during extraction of folates. The quantity of 10-CHO-H4PteGlu in the extracts could not be explained by such conversion.
To determine the proportion of intracellular folates which were present as short-chain and long-chain folates (poly-y-glutamates), cell extracts were filtered 1022 Rosenblatt, Cooper, Lue-Shing, Wong, Berlow, Narisawa, and Baumgartner through Sephadex G-25 and assayed for microbiological activity after deconjugation. The proportion of folate which was present in the excluded volume of the column and thus presumed to be polyglutamates (17) was not different in control and mutant cells (Table IV) . The proportion of 5-CH3-H4PteGlu within the polyglutamate fraction was decreased in mutant cells. This study indicates that the enzyme deficiency is reflected by a relative lack of 5-CH3-H4PteGlu in the folate polyglutamate fraction and in the total folate of the cell.
The relationship between the proportion of cellular folate as 5-CH3-H4PteGlu and the residuial level of the mutant enzyme in the mutant cells is shown in Fig. 2 . The residual level of enzyme was determined by comparing the rnutant enzyme activity to the mean control level for the individual laboratory where the patient was studied. There was a direct relationship between the residual activity and the proportion ofcellular folate as 5-CH3-H4PteGlu (r = 0.94, P = 0.0001). When patients were ranked as to clinical severity (Table I) there was again a strong correlation between clinical findings and cellular 5-CH3-H4PteGlu fraction (r = -0.95, P = 0.00005). When these were compared with the intracellular concentration of 5-CH3-H4PteGlu rather than with the proportion of intracellular folate in this form, correlation was observed, but this was less than with the latter (r = 0.69 and 0.71, P = 0.029 and 0.013, respectively). A strong relationship was observed also between the proportion of intracellular folate which supported growth of L. casei in extracts, but did not support P. cerevisiae and both residual enzyme activity (Table II) .
and clinical severity of the illness (r = 0.835 and -0.088, P = 0.0025 and 0.0008, respectively). DISCUSSION These studies demonstrate the accumulation of polyglutamates of 5-CH3-H4PteGlu as the major intracellular folate in fibroblasts grown in PteGlu, and the distribution of nonmethylated folates most of which were also in the polyglutamate form. The conditions of extraction and analysis of intracellular folate allowed chemical interconversion of some ofthese; indeed conversion of 5-10-CH=H4PteGlu to 10-CHO-H4PteGlu, 10-CHO-PteGlu, and 5-CHO-H4PteGlu was demonstrated during the procedure. The major folate fractions in the cell extracts after conversion of polyglutamate to monoglutamate folate were 5-CH3-H4PteGlu and 10-CHO-H4PteGlu, and smaller quantities of 10-CHOPteGlu, 5-CH3-H2PteGlu, and H4PteGlu were also found. Of the last three, 10-CHO-PteGlu and 5-CH3-H2PteGlu could have been formed during extraction and chromatography despite the presence of ascorbate and mercaptoethanol in the solutions, and much of the H4PteGlu could have been derived from 5-10-CH2-H4-PteGlu which would have been converted to H4PteGlu under the conditions of analysis. The data presented do, however, define the major intracellular folate as 5-CH3-H4PteGlu, and 10-CHO-H4PteGlu as the major nonmethylated folate. 5-CHO-H4PteGlu may not be present within the unextracted cells.
Folate Distribution in 5,10-CH2-H4PteGlu Reductase Deficiency
The mutant cells, deficient in 5,10-CH2-H4PteGlu reductase, contained the same intracellular concentration of folate, and the same group of folate coenzymes, although in all cases, the proportion of intracellular folate which was 5-CH3-H4PteGlu folate was decreased below that of control cells. The deficiency of intracellular 5-CH3-H4PteGlu in mutant cells was not surprising, because the deficient enzyme is considered the major pathway for formation of this folate. It was of interest to note that compensatory metabolic adjustments to correct this imbalance were not observed, and the only defect observed in growth was the previously described dependence of mutant cells on methionine as a growth factor not required by normal cells in the presence of homocysteine (5) .
The patients from whom these fibroblasts were obtained had a variety of different clinical syndromes including psychological, neurological, and developmental abnormalities. Clinical ranking of the severity of their illness correlated very well with the residual enzyme activity and with the proportion of intracellular folate which was 5-CH3-H4PteGlu, and less well with the absolute concentration of this folate within the cultured cells. The absolute concentration of 5-CH3-H4PteGlu was usually, but not always lower in mutant cells than in normal cells, suggesting that this intracellular concentration might not be the critical determinant of cellular metabolism. The close correlation of the proportion of intracellular folate which was 5-CH3-H4PteGlu with residual enzyme activity and clinical severity of disease suggests that the relative distribution of different folate coenzymes might be important in controlling folate-related metabolism. Such control might depend on competition by different folates for folate-dependent enzymes, so that excess or deficiency of one folate form might alter the availability of other folates for enzymes. Competition has been reported by 10-CHO-H4PteGlu, H2PteGlu, PteGlu, and PteGlu5 for human thymidylate synthetase with its natural coenzyme (21) . The least-squares line comparing residual enzyme concentration with proportion of intracellular 5-CH3-H4PteGlu passed through the origin of the graph, indicating that the pathway uses the enzyme 5-10-CH2-H4PteGlu reductase is the only significant one for producing 5-CH3-H4PteGlu in these cells, under these conditions ofgrowth. The total intracellular folate of both mutant and normal cells was equal, indicating that failure to convert intracellular folate to 5-CH3-H4-PteGlu does not affect folate accumulation by human fibroblasts in vitro. The intracellular folate concentration in human fibroblasts grown in PteGlu does not exceed that of the PteGlu in the culture medium (22) .
Comparison of the proportion of intracellular folate which was 5-CH3-H4PteGlu, determined by chromatography with that by differential microbiological assay alone showed poor correlation, but that calculated by the latter was consistently higher when either S. fecalis or P. cerevisiae was compared with L. casei. This suggests that some of the nonmethyl folates were much more effectively used by L. casei for growth than by the two other test organisms. Differential microbiological assay alone on extracts of cultured fibroblasts however, does appear to be a good screening test for 5,10-Ch2-H4-PteGlu reductase deficiency.
